These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 27796023)

  • 1. [Clinical Manifestations in Autosomal Dominant Polycystic Kidney Disease (ADPKD)].
    Piscopo G; Capolongo G
    G Ital Nefrol; 2016; 33(5):. PubMed ID: 27796023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Manifestations of Autosomal-Dominant Polycystic Kidney Disease.
    Mikolajczyk AE; Te HS; Chapman AB
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):17-24. PubMed ID: 27374006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autosomal dominant policystic kidney disease, more than a renal disease.
    Torra R
    Minerva Endocrinol; 2014 Jun; 39(2):79-87. PubMed ID: 24736482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal dominant polycystic kidney disease.
    Srivastava A; Patel N
    Am Fam Physician; 2014 Sep; 90(5):303-7. PubMed ID: 25251090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrarenal manifestations of autosomal dominant polycystic kidney disease.
    Ha SK; Park CH; Kna JS; Lee SY; Lee JI; Kim SJ; Seo JK; Lee HY; Han DS
    Yonsei Med J; 1997 Apr; 38(2):111-6. PubMed ID: 9175489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic kidney disease: etiology, pathogenesis, and treatment.
    Martinez JR; Grantham JJ
    Dis Mon; 1995 Nov; 41(11):693-765. PubMed ID: 7587886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ADPKD and intracranial aneurysms: indications for screening, follow-up and clinical management].
    Econimo L; Zeni L; Cortinovis R; Alberici F; Izzi C; Scolari F
    G Ital Nefrol; 2021 Oct; 38(5):. PubMed ID: 34713642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
    Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
    Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant polycystic kidney disease: Study of clinical characteristics in an Indian population.
    Vikrant S; Parashar A
    Saudi J Kidney Dis Transpl; 2017; 28(1):115-124. PubMed ID: 28098112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autosomal dominant polycystic kidney disease: pathophysiology and treatment.
    McCarthy S; McMullen M
    ANNA J; 1997 Feb; 24(1):45-51; quiz 52-3. PubMed ID: 9146123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the clinical management of autosomal dominant polycystic kidney disease.
    Torra R
    F1000Res; 2019; 8():. PubMed ID: 30755792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian manifestations in women with autosomal dominant polycystic kidney disease.
    Heinonen PK; Vuento M; Maunola M; Ala-Houhala I
    Am J Kidney Dis; 2002 Sep; 40(3):504-7. PubMed ID: 12200801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial cysts in autosomal dominant polycystic kidney disease.
    Schievink WI; Huston J; Torres VE; Marsh WR
    J Neurosurg; 1995 Dec; 83(6):1004-7. PubMed ID: 7490613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
    Masoumi A; Elhassan E; Schrier RW
    Iran J Kidney Dis; 2011 Jan; 5(1):1-8. PubMed ID: 21189426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): considerations for routine screening and management.
    Luciano RL; Dahl NK
    Nephrol Dial Transplant; 2014 Feb; 29(2):247-54. PubMed ID: 24215018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ADPKD and Heart].
    Liut F; Izzi C; Dallera N; Scolari F
    G Ital Nefrol; 2017 Mar; 34(Suppl 69):119-130. PubMed ID: 28682033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic and renal manifestations in autosomal dominant polycystic kidney disease: a dichotomy of two ends of a spectrum.
    van Gulick JJ; Gevers TJ; van Keimpema L; Drenth JP
    Neth J Med; 2011 Sep; 69(9):367-71. PubMed ID: 21978978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatment paradigms for ADPKD: moving towards precision medicine.
    Lanktree MB; Chapman AB
    Nat Rev Nephrol; 2017 Dec; 13(12):750-768. PubMed ID: 28989174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary Tract and Liver Complications in Polycystic Kidney Disease.
    Judge PK; Harper CHS; Storey BC; Haynes R; Wilcock MJ; Staplin N; Goldacre R; Baigent C; Collier J; Goldacre M; Landray MJ; Winearls CG; Herrington WG
    J Am Soc Nephrol; 2017 Sep; 28(9):2738-2748. PubMed ID: 28465378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonographic study of pancreatic cysts in autosomal dominant polycystic kidney disease.
    Torra R; Nicolau C; Badenas C; Navarro S; Pérez L; Estivill X; Darnell A
    Clin Nephrol; 1997 Jan; 47(1):19-22. PubMed ID: 9021236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.